Texar S 250mg/125mg Injection
Marketer
Arlak Biotech Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Texar S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action medication, combats various bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration must be under a physician's direct guidance; strict adherence to the prescribed schedule is crucial. Complete the full course, even with symptom improvement; premature cessation may reduce efficacy. Nausea, vomiting, diarrhea, and indigestion are potential side effects; worsening symptoms necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your doctor of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving is discouraged if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order tests to monitor the medication's effects.
Primary Ingredients of Texar S 250mg/125mg Injection
There is no text provided to rephrase.
Uses of Texar S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Texar S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Texar S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Texar S 250mg/125mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strongly discouraged.
How Texar S 250mg/125mg Injection works:
Ceftriaxone 250mg and Sulbactam 125mg Injection (Texar S) combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to thrive. The addition of Sulbactam, by countering bacterial resistance mechanisms, significantly boosts Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Texar S 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Texar S (250mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; clinical data from human trials, however, remain scarce.
Breast feedingCAUTION
The administration of Texar S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Texar S 250mg/125mg Injection might induce drowsiness, blurred vision, or dizziness. Operating a vehicle is discouraged should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Texar S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Texar S 250mg/125mg Injection requires careful consideration in individuals with significant hepatic impairment. Dosage modification for Texar S 250mg/125mg Injection may be necessary. Physician consultation is advised. Altering the dose of Texar S 250mg/125mg Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Texar S 250mg/125mg Injection :
Should you forget a scheduled dose of Texar S 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Texar S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently